Scheme 5From: Synthesis of novel mono- and bis-pyrazolylthiazole derivatives as anti-liver cancer agents through EGFR/HER2 target inhibitionReaction of bis(thiosemicarbazones) 20a–c with bromoacetylpyrazole 6Back to article page
